
Affordable HIV Prevention Injection Expands Global Access
A Breakthrough in HIV Prevention The availability of a long-acting HIV prevention injection at an affordable cost is poised to change the global fight against the virus. Lenacapavir, a twice-yearly injectable drug, blocks HIV replication and provides six months of continuous protection with each dose. While initial market prices exceeded











